✓ Twelve patients with Hunt and Hess neurological Grades III to V underwent thrombosis of aneurysms using cellulose acetate polymer within 23 hours of aneurysm rupture. On computerized tomography (CT), nine of these patients had diffuse or localized thick subarachnoid blood clots, two had diffuse thin clots, and one had intraventricular clots. Immediately after thrombosis, all patients were administered tissue plasminogen activator (TPA) through spinal or ventricular catheters. The pressure of the lumbar cerebrospinal fluid was maintained at 100 to 150 mm H2O. The TPA was given as multiple injections of 2 mg on Day 0 and 1 to 2 mg on the following 1 to 2 days. In two patients the second injection of TPA was not given because of severe brain damage resulting from the initial subarachnoid hemorrhage. Ten patients showed complete clearance of the cisternal clot on CT within 72 hours after thrombosis. Seven partially thrombosed aneurysms and five multiple aneurysms were clipped during delayed surgery. Only one patient experienced mild vasospasm as shown on the follow-up angiogram. Eight patients improved clinically and had a good recovery, two had severe disability, and two died. Urgent thrombosis of a ruptured aneurysm followed by immediate postthrombotic administration of TPA may be a safe and reasonable means of preventing vasospasm and improving patient outcome.
Dublin AB, & French BN: Cerebral aneurysmal rupture during angiography with confirmation by computed tomography: a review of intra-angiographic aneurysmal rupture. Surg Neurol 13:19–27, 1980 Dublin AB, French BN: Cerebral aneurysmal rupture during angiography with confirmation by computed tomography: a review of intra-angiographic aneurysmal rupture. Surg Neurol 13:19–27, 1980
Findlay JM, , Weir BKA, & Kanamaru K, et al: The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26:201–206, 1990 Findlay JM, Weir BKA, Kanamaru K, et al: The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26:201–206, 1990
Findlay JM, , Weir BKA, & Kassell NF, et al: Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181–188, 1991 Findlay JM, Weir BKA, Kassell NF, et al: Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181–188, 1991
Fisher CM, , Kistler JP, & Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9, 1980 Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9, 1980
Grote E, & Hassler W: The critical first minutes after subarachnoid hemorrhage. Neurosurgery 22:654–661, 1988 Grote E, Hassler W: The critical first minutes after subarachnoid hemorrhage. Neurosurgery 22:654–661, 1988
Hunt WE, & Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20, 1968 Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20, 1968
Inagawa T, , Yamamoto M, & Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224–230, 1990 Inagawa T, Yamamoto M, Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224–230, 1990
Jennett B, & Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484, 1975 Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484, 1975
Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:323–326, 1989 Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:323–326, 1989
Kassell NF, & Torner JC: Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:479–481, 1983 Kassell NF, Torner JC: Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:479–481, 1983
Kassell NF, , Torner JC, & Haley EC Jr, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg 73:18–36, 1990 Kassell NF, Torner JC, Haley EC Jr, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg 73:18–36, 1990
Kassell NF, , Torner JC, & Jane JA, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg 73:37–47, 1990 Kassell NF, Torner JC, Jane JA, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg 73:37–47, 1990
Kinugasa K, , Mandai S, & Date I, et al: Direct thrombosis of aneurysms. J Neurosurg 78:1007–1008, 1993 (Letter) Kinugasa K, Mandai S, Date I, et al: Direct thrombosis of aneurysms. J Neurosurg 78:1007–1008, 1993 (Letter)
Kinugasa K, , Mandai S, & Kamata T, et al: Prophylactic thrombosis to prevent rebleeding and to delay aneurysm surgery. Neurosurgery 36:661–667, 1994 Kinugasa K, Mandai S, Kamata T, et al: Prophylactic thrombosis to prevent rebleeding and to delay aneurysm surgery. Neurosurgery 36:661–667, 1994
Kinugasa K, , Mandai S, & Terai Y, et al: Direct thrombosis of aneurysms with cellulose acetate polymer. Part II: preliminary clinical experience. J Neurosurg 77:501–507, 1992 Kinugasa K, Mandai S, Terai Y, et al: Direct thrombosis of aneurysms with cellulose acetate polymer. Part II: preliminary clinical experience. J Neurosurg 77:501–507, 1992
Kinugasa K, , Mandai S, & Tsuchida S, et al: Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms: angiographic findings, clinical experience, and histopathological study. Neurosurgery 34:694–701, 1994 Kinugasa K, Mandai S, Tsuchida S, et al: Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms: angiographic findings, clinical experience, and histopathological study. Neurosurgery 34:694–701, 1994
Kinugasa K, , Mandai S, & Tsuchida S, et al: Direct thrombosis of a pseudoaneurysm after obliteration of a carotid-cavernous fistula with cellulose acetate polymer: technical case report. Neurosurgery 35:755–760, 1994 Kinugasa K, Mandai S, Tsuchida S, et al: Direct thrombosis of a pseudoaneurysm after obliteration of a carotid-cavernous fistula with cellulose acetate polymer: technical case report. Neurosurgery 35:755–760, 1994
Ljunggren B, , Brandt L, & Kågström E, et al: Results of early operations for ruptured aneurysms. J Neurosurg 54:473–479, 1981 Ljunggren B, Brandt L, Kågström E, et al: Results of early operations for ruptured aneurysms. J Neurosurg 54:473–479, 1981
Ljunggren B, , Säveland H, & Brandt L, et al: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:547–551, 1985 Ljunggren B, Säveland H, Brandt L, et al: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:547–551, 1985
Mandai S, , Kinugasa K, & Ohmoto T: Direct thrombosis of aneurysms with cellulose acetate polymer. Part I: results of thrombosis in experimental aneurysms. J Neurosurg 77:497–500, 1992 Mandai S, Kinugasa K, Ohmoto T: Direct thrombosis of aneurysms with cellulose acetate polymer. Part I: results of thrombosis in experimental aneurysms. J Neurosurg 77: 497–500, 1992
Mizoi K, , Yoshimoto T, & Takahashi A, et al: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430–437, 1993 Mizoi K, Yoshimoto T, Takahashi A, et al: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430–437, 1993
Mizukami M, , Kawase T, & Usami T, et al: Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10:301–307, 1982 Mizukami M, Kawase T, Usami T, et al: Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10:301–307, 1982
Mizukami M, , Usami T, & Tazawa T, et al: Prevention of vasospasm by removal of subarachnoid blood in early operation. Neurol Med Chir 21:1069–1077, 1981 Mizukami M, Usami T, Tazawa T, et al: Prevention of vasospasm by removal of subarachnoid blood in early operation. Neurol Med Chir 21:1069–1077, 1981
Nornes H: The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. J Neurosurg 39:226–234, 1973 Nornes H: The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. J Neurosurg 39:226–234, 1973
Ogura K, , Hara M, & Tosaki F, et al: Effect of cisternal drainage after early operation for ruptured intracranial aneurysms. Surg Neurol 30:441–444, 1988 Ogura K, Hara M, Tosaki F, et al: Effect of cisternal drainage after early operation for ruptured intracranial aneurysms. Surg Neurol 30:441–444, 1988
Öhman J, , Servo A, & Heiskanen O: Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:197–201, 1991 Öhman J, Servo A, Heiskanen O: Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:197–201, 1991
Paré L, , Delfino R, & Leblanc R: The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg 76:422–427, 1992 Paré L, Delfino R, Leblanc R: The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg 76:422–427, 1992
Rudd TG, , O'Neal JT, & Nelp WB: Cerebrospinal fluid circulation following subarachnoid hemorrhage. J Nucl Med 12:61–63, 1971 Rudd TG, O'Neal JT, Nelp WB: Cerebrospinal fluid circulation following subarachnoid hemorrhage. J Nucl Med 12:61–63, 1971
Seifert V, , Eisert WG, & Stolke D, et al: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:590–598, 1989 Seifert V, Eisert WG, Stolke D, et al: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:590–598, 1989
Serbinenko FA: Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 41:125–145, 1974 Serbinenko FA: Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 41:125–145, 1974
Sugiu K, , Kinugasa K, & Mandai S, et al: Direct thrombosis of experimental aneurysms with cellulose acetate polymer. Technical aspects, angiographic follow up, and histological study. J Neurosurg 83:(In press, 1995) Sugiu K, Kinugasa K, Mandai S, et al: Direct thrombosis of experimental aneurysms with cellulose acetate polymer. Technical aspects, angiographic follow up, and histological study. J Neurosurg 83: (In press, 1995)
Suzuki J, , Mizoi K, & Yoshimoto T: Bifrontal interhemispheric approach to aneurysms of the anterior communicating artery. J Neurosurg 64:183–190, 1986 Suzuki J, Mizoi K, Yoshimoto T: Bifrontal interhemispheric approach to aneurysms of the anterior communicating artery. J Neurosurg 64:183–190, 1986
Teasdale G, & Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84, 1974 Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84, 1974
Tsementzis SA, , Kennett RP, & Hitchcock ER: Rupture of intracranial vascular lesions during arteriography. J Neurol Neurosurg Psychiatry 47:795–798, 1984 Tsementzis SA, Kennett RP, Hitchcock ER: Rupture of intracranial vascular lesions during arteriography. J Neurol Neurosurg Psychiatry 47:795–798, 1984
Zabramski JM, , Spetzler RF, & Lee KS, et al: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189–196, 1991 Zabramski JM, Spetzler RF, Lee KS, et al: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189–196, 1991
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 575 | 71 | 1 |
Full Text Views | 166 | 3 | 0 |
PDF Downloads | 110 | 1 | 0 |
EPUB Downloads | 0 | 0 | 0 |